Targeting Chordoma Spinal Tumors Using Rational Drug Design 2020 Partnership with Chordoma Foundation David Drewry, PhD, University of North Carolina, Chapel Hill; Opher Gileadi, PhD, University of Oxford; Paul Workman, PhD, Institute for Cancer Research Read More
Using a High-Fiber Diet to Improve Melanoma Patients’ Response to Immunotherapy 2019 ASPIRE Award Jennifer McQuade, MD, MS (Principal); Jennifer Wargo, MD, MMSc; and Carrie Daniel-MacDougall, PhD, MPH, The University of Texas MD Anderson Cancer Center Read More
Using an FDA-Approved, Anti-Arthritis Drug to Improve Outcomes in Pancreatic Ductal Adenocarcinoma (PDAC) 2019 ASPIRE Award Cullen Taniguchi, MD, PhD (Principal); Anirban Maitra, MD; and Eugene Jon Koay, MD, The University of Texas MD Anderson Cancer Center Read More
Investigating a New Drug Target in Pancreatic Ductal Adenocarcinoma (PDAC) 2019 ASPIRE Award Lewis C. Cantley, PhD (Principal), Weill Cornell Medicine and Costas A. Lyssiotis, PhD, University of Michigan Read More
Virotherapy for Malignant Gliomas 2019 ASPIRE Award Nduka Amankulor, MD (Principal), University of Pennsylvania and Joseph Glorioso, PhD, University of Pittsburgh Medical Center Read More
Investigating the Relationship between Genetics and Patient Response to Immunotherapy 2019 ASPIRE II Award Edison Liu, MD (Principal); Laura Reinholdt, PhD (Co-Principal); Lucas Chang, PhD; Daniel Skelly, PhD, The Jackson Laboratory Read More
